Tizanidine Tablet
Product Images NDC 71335-2325

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 71335-2325). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Fig1)

A line graph depicting plasma concentration of Tizanidine (ng/mL) over time (hours) from dosing. It compares 2 doses of 4 mg Tizanidine tablets and capsules taken with and without food, showing concentration changes up to 24 hours post-dose.*

FDA Label Image

Fig2 (Fig2)

Line graph showing improvement in Ashworth Score over 6 hours post-dose comparing 16 mg tizanidine, 8 mg tizanidine, and placebo groups. The vertical axis measures improvement in Ashworth Score, while the horizontal axis shows hours after dosing. The 16 mg dose demonstrates the greatest improvement followed by 8 mg, with placebo showing minimal change.*

FDA Label Image

Fig3 (Fig3)

A line chart comparing improvement in Ashworth Score over time between tizanidine (mean dose 28.8 mg) and placebo groups at three study points: end of titration (week 3), end of maintenance (week 7), and endpoint (last observation carried forward). Error bars indicate variability at each time point.*

FDA Label Image

Label (Lbl713352325)

Label for Tizanidine Tablets USP, 4 mg oral tablets, packaged in a container of 30 tablets. The label shows the NDC 71335-2325-1 with dosing strength emphasized. It notes that each tablet contains 4.576 mg of Tizanidine Hydrochloride USP equivalent to 4 mg Tizanidine base. Labeler is Bryant Ranch Prepack, repackaged from Dr. Reddys Laboratories Ltd. Storage and safety instructions are also included.*

FDA Label Image

Structure (Structure)

Chemical structure of Tizanidine hydrochloride, depicting its molecular framework with a fused bicyclic ring and side chain containing nitrogen atoms.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.